PATENT CLAIM ANALYSIS

Application Number: 16377465
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-07
Patent Classification: ["436", "501000"]

Abstract:
The present invention relates to an in vitro method for the prognosis of an adverse event in asymptomatic subjects comprising the determination of the level of Procalcitonin (PCT) or a fragment thereof or a precursor or fragment thereof having at least 12 amino acid residues in a sample of a bodily fluid from said subject and the correlation of the determined level to a potential risk of sustaining an adverse event.

Claim (Index 20):
The method of  claim 18 , wherein said PCT fragment comprises (contains)\n at least 12 amino acids, preferably more than 50 amino acids, most preferably more than 100 amino acids, or the amino acids 2 to 116 or 3 to 116 of the amino acid sequence shown as SEQ ID NO. 1.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 100.0
- Lexical Diversity: 1.5102
- Patent Class: 436.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15211802', '14391953', '12671823', '14223517', '14939595']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6931635593989028
- 35 USC 102 Novelty (BERT): 0.5131993296813135
- Combined Prediction Score: 0.6751671364271439
- Mean Citation Score: 244.818922
- Max Citation Score: 311.54398
- Similarity Product: 185.6836337644994

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test